Real-World Success in Nigeria: Six-Month Regimens, Accelerated by PeerLINC

A programmatic review of more than 200 people in Nigeria treated with BPaL/M, found 89% treatment success rates among with MDR/RR-TB and 100% for the smaller pre-XDR cohort. PeerLINC has helped to close critical training gaps in the country, which help to support effective and widespread scale-up of the regimens.